Clin2
NCT06667726Likely a fitRecruiting

New PET scan for better brain tumor care

Malignant Brain Neoplasm

Part of Brain & nervous system, Cancer clinical trials.

This trial studies a special PET scan called 18F-DOPA PET/CT to see if it can help doctors better manage brain tumors. It may be used before surgery, for radiation planning, or when MRI results are unclear.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
47 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been diagnosed with a brain tumor
  • Your doctor recommends an amino acid PET scan for reasons like planning surgery, radiation, or checking if a tumor is growing or responding to treatment
  • You are able to give consent for the study, or have someone who can do it for you

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05512403Recruiting· Phase 3
Test of FDOPA PET scan to evaluate a brain tumor

This study checks how well an FDOPA PET scan can identify and describe a specific type of brain tumor at the beginning. Results may help doctors decide on the best next steps for diagnosis and treatment planning.

Vandœuvre-lès-Nancy
NCT07599917Not yet recruiting
Brain scan study for tumor diagnosis and treatment response

This study uses a special PET scan to look at brain tumors (both new and returning) to help doctors understand them better and see how well treatment is working.

NCT07023640Recruiting
Imaging test for tumors using a new tracer agent

This trial tests a new imaging method (68Ga-DOTA-mPNE PET/CT) to see if it can help detect cancers. It's for people who haven't had chemotherapy or radiation yet and will have a biopsy or surgery.

Beijing, Beijing Municipality
NCT06474533Recruiting
FET PET for evaluating brain tumors

This study tests a special imaging agent called fluoroethyltyrosine (FET) to see if it can better detect brain tumors on PET scans. It may help doctors decide if a tumor has come back after treatment or better guide initial biopsy or surgery.

San Francisco, California
NCT06172595Recruiting· Phase 2
PET scan to tell tumor growth from treatment effects in brain cancer

This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.

Singapore
NCT04111588Recruiting
PET/MRI scan to assess brain tumors and metastases

This trial tests how well a special PET/MRI scan can help doctors evaluate gliomas and brain metastases. It may help improve diagnosis and treatment planning by comparing scan results with tissue samples or surgery findings.

Bergen

Hear when a new Malignant Brain Neoplasm trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.